AI Improves prostate cancer (PCa) detection: Clinical Validation of AI models

Published on: June 24, 2025
Categories: News
ProCAncer-I results | Prof. Daniele Regge on clinical validation

In this video, we present the results of the clinical validation of AI models that were developed during the ProCAncer-i Project. Clinical validation is a critical step to ensure that AI tools not only perform well in controlled settings, but also truly assist radiologists in daily practice. Two AI models were tested. Radiologists read 160 prostate exams first without AI, then re-read them six weeks later with AI assistance. Key Takeaways: AI improved sensitivity and specificity compared to unassisted readings, though not always with statistical significance. AI reduced reading time by 15 to 21 seconds per exam.

Bottom Line: AI can meaningfully improve radiologist performance, especially for those with lower baseline accuracy, and it can help save valuable reading time.

Watch it here:

Highlights

Podcast Spotlight: The Future of Trustworthy AI in Healthcare

Podcast Spotlight: The Future of Trustworthy AI in Healthcare

The role of artificial intelligence (AI) in healthcare is expanding rapidly, but trust remains a crucial barrier to its widespread adoption. The following AI-generated audio file, titled, serves as an example of how AI-driven technologies can contribute to medical research and education.

Dissemination Event of the ProCAncer-I Project in Vienna, Austria

Dissemination Event of the ProCAncer-I Project in Vienna, Austria

ProCAncer-I organised the 4th Dissemination Event of the project at the ECR 2025 held in Vienna, Austria, February 25-26, 2025. During the congress, ProCAncer-I organised a Dedicated Session on the project on the 26th of February 2025, at 15.00-16.00, with the title...

Stay in touch!